$AMBS "The immediate focus for Amarantus with rega

$AMBS "The immediate focus for Amarantus with regards to our wholly-owned subsidiary Elto Pharma is to ensure that we maximize the current value inherent in the eltoprazine asset, where a recent independent third party valuation places the value of eltoprazine in PD-LID alone in the US and Europe at approximately 30x the entire current market capitalization of Amarantus," said Gerald E. Commissiong, President & CEO of Amarantus and interim-CEO of Elto Pharma. "With the capital restructuring of Amarantus nearing its final stages, we believe we will soon be positioned to properly execute upon our Elto Pharma strategy. Ultimately, we see value not only from the PD-LID orphan indication for eltoprazine, which we expect to appreciate significantly over time as the PD-LID indication is further clinically de-risked, but we also intend to see the Agitation in Alzheimer's disease and Adult ADHD indications for Eltoprazine become valued by the market as Elto Pharma executes upon its clinical development strategy."

https://finance.yahoo.com/news/amarantus-prov...46167.html

Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!